Novo launches new drug in Mexico
Mexico will be the first country in the world where patients can benefit from Novo Nordisk’s new combination treatment, Ryzodeg.
BY STEFAN SINGH KAILAY
Danish drug group Novo Nordisk has turned its attention to Mexico. It was here, in Mexico City, that the company chose to launch a new, focused strategy dubbed ‘Cities Changing Diabetes’, and it is here that the company has now chosen to launch its combination treatment Ryzodeg, on the first market in the world.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Novo accepts fine in Tresiba case
For abonnenter
Analyst: Novo case is a matter of principle
For abonnenter
Novo reported to the police by Danish FSA
For abonnenter
